Delaware Crossing Investor Group

Delaware Crossing Investor Group is a private equity and venture capital firm based in Warrington, Pennsylvania, founded in 2005. The firm focuses on providing counsel and capital to early-stage and growth-oriented companies, primarily in the software, Internet, information technology, life sciences, advanced materials, functional chemicals, consumer products, and medical device sectors. It operates as a membership organization comprised of qualified investors who actively participate in sourcing potential portfolio companies, managing the investment process, and serving on the boards of those companies. Delaware Crossing Investor Group targets businesses seeking funding between $250,000 and $1,000,000, typically limiting individual investments to around $250,000. The firm serves companies in the Philadelphia and Doylestown areas of Pennsylvania, as well as Princeton, New Jersey.

Elizabeth Sigety

Co-Founder, Managing Director and Member

15 past transactions

Vytala

Pre Seed Round in 2024
Vytala is a food technology company specializing in clinical nutrition. It operates by offering a unique structured lipid technology that enhances nutrient absorption, particularly for those with fat malabsorption issues. This technology helps clients avoid nutrient deficiencies, gastrointestinal diseases, and chronic malnutrition, supporting overall health and well-being.

Measure Studio

Seed Round in 2023
Measure Studio operates a content intelligence engine that aids users in developing data-driven social media strategies. The platform serves digital publishers, brands, agencies, and influencers by providing a secure environment to consolidate and analyze social media data. By facilitating better management of social media analytics across various platforms, Measure Studio empowers its users to create more effective and engaging content based on insights derived from their data.

SunRay Scientific

Venture Round in 2022
SunRay Scientific LLC is a manufacturer of advanced materials based in Long Branch, New Jersey, specializing in conductive adhesives that facilitate the assembly of flexible electronics. Founded in 1998, the company provides innovative solutions, including conductive inks, epoxies, and encapsulants, designed to enhance flexible circuitry in next-generation wearable electronics and semiconductor packaging. SunRay Scientific caters to various industries, including healthcare, military defense, automotive, and consumer electronics, by enabling high throughput processes in flexible electronics assembly. The company generates revenue through material sales, licensing, and engineering services, contributing to the advancement of flexible hybrid and miniaturized electronics.

Vesteck

Series A in 2021
Vesteck is a clinical stage medical device company dedicated to advancing proprietary technology in the aortic repair, structural heart, and gastrointestinal markets. The company's flagship product, the Suture-Tight™ nitinol suture delivery catheter, offers an innovative solution for endovascular aortic repair by securely suturing grafts to the aorta during initial implantation. This technology addresses critical challenges such as graft migration and leaks, which can lead to complex and costly repairs. By improving the efficacy of aortic repairs and providing significant benefits to healthcare providers, payors, and patients, Vesteck aims to enhance patient outcomes in the treatment of aortic aneurysms and related conditions.

Ophidion

Venture Round in 2019
Ophidion is a biotechnology company that specializes in developing therapeutics for the central nervous system by delivering treatments directly to targeted sites in the brain. Utilizing a Trojan horse strategy, Ophidion exploits an endogenous receptor-mediated transport system to facilitate the intravenous delivery of small molecule drugs and biologics, including gene-silencing therapies. The company focuses on treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. Its platform is versatile, allowing for the delivery of various drug classes, including oligonucleotides, small interfering RNAs (siRNAs), antibodies, and peptides. Additionally, Ophidion has an advanced program aimed at addressing anxiety-related disorders, which includes a patented companion biomarker diagnostic to identify suitable patient populations for treatment.

ThruPore

Seed Round in 2018
ThruPore Technologies Inc., established in 2012 and based in Bear, Delaware, specializes in the development and production of porous carbon support structures for industrial catalysts. The company manufactures heterogeneous catalysts in pellet and powder forms, initially focusing on palladium on carbon reactions. ThruPore's products cater to clients in the precious metal catalysts, carbon-only catalysts, fuel cell, and battery materials industries, offering superior catalysts that enhance dispersion and improve end product refinement.

Tobly

Convertible Note in 2017
Tobly operates an online rental platform specializing in construction equipment. The company provides a range of rental services for major equipment, including cranes, scissor lifts, and excavators. Through its cloud-based platform, Tobly enables clients to efficiently manage the entire lifecycle of the equipment rental process, facilitating a seamless experience for users in the construction industry.

OnlySky

Seed Round in 2017
OnlySky offers a customizable cloud-based platform tailored for ski areas, enabling guests to create their ideal skiing experience directly on the ski area's website. The platform allows ski area staff to efficiently manage inventory, eCommerce, point-of-sale transactions, ski school operations, and events from a single interface. With no upfront fees and user-friendly design, it serves as an appealing solution for independent ski areas across North America and snow schools globally. By facilitating services such as equipment rentals and instructor bookings through mobile devices, OnlySky streamlines operations and enhances guest engagement, ultimately improving the overall skiing experience.

Life.io

Seed Round in 2016
Life.io is the world’s first web-based platform specifically designed to help people make better decisions every moment, to take care of themselves more, to engage more, to simply live more. Delivered through insurance companies or employers, it’s always on, sharing inspired ideas on how to live better today and every day after.

Annovis Bio

Series A in 2015
Annovis Bio, Inc. is a clinical-stage pharmaceutical company based in Berwyn, Pennsylvania, specializing in the development of treatments for neurodegenerative disorders, particularly Alzheimer's disease and Parkinson's disease. The company is advancing several compounds in clinical trials, with its lead candidate, ANVS401, currently in Phase 2a trials aimed at treating Alzheimer’s disease, Parkinson’s disease, and other chronic neurodegenerative conditions. Additionally, Annovis is developing ANVS405, which focuses on providing neuroprotection following traumatic brain injuries and strokes, and ANVS301, which is in Phase I trials designed to enhance cognitive function in later stages of Alzheimer’s disease and dementia. Founded in 2008, Annovis Bio is dedicated to creating innovative therapies to address the challenges posed by these debilitating diseases.

Hulafrog

Seed Round in 2013
Hulafrog, Inc. operates a network of local websites and digital community guides that connect parents with kid-focused events and businesses in their neighborhoods. Founded in 2010 and headquartered in Atlantic Highlands, New Jersey, the company provides a platform for parents to discover activities such as fairs, festivals, classes, camps, and family-friendly restaurants. Additionally, Hulafrog allows local business owners to promote their offerings and events to a targeted audience of parents seeking family-oriented products and services. The website features a business directory, an event calendar, and newsletters that aggregate and curate local activities, while also offering advertising packages for businesses to reach their desired clientele.

Novira Therapeutics

Series A in 2013
Novira Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Doylestown, Pennsylvania, focused on discovering and developing antiviral drugs for chronic hepatitis B (HBV) and human immunodeficiency virus (HIV) infections. The company specializes in creating first-in-class oral therapeutics that target the capsid of these viruses, offering potential treatment options that address significant limitations in current therapies. Novira's innovative capsid inhibitors can be used alone or in conjunction with existing treatments, aiming to overcome challenges such as drug resistance and the need for lifelong therapy, particularly in chronic HBV infection, where existing polymerase inhibitors are rarely curative. Founded in 2006, Novira Therapeutics operates as a subsidiary of Johnson & Johnson, reflecting its strategic importance in addressing global health needs related to antiviral treatment.

Novira Therapeutics

Seed Round in 2011
Novira Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Doylestown, Pennsylvania, focused on discovering and developing antiviral drugs for chronic hepatitis B (HBV) and human immunodeficiency virus (HIV) infections. The company specializes in creating first-in-class oral therapeutics that target the capsid of these viruses, offering potential treatment options that address significant limitations in current therapies. Novira's innovative capsid inhibitors can be used alone or in conjunction with existing treatments, aiming to overcome challenges such as drug resistance and the need for lifelong therapy, particularly in chronic HBV infection, where existing polymerase inhibitors are rarely curative. Founded in 2006, Novira Therapeutics operates as a subsidiary of Johnson & Johnson, reflecting its strategic importance in addressing global health needs related to antiviral treatment.

Compliance Assurance

Venture Round in 2011
Compliance Assurance Corporation specializes in on-demand governance, risk, and compliance solutions tailored specifically for the insurance industry. Founded in 2003 and based in Pittsburgh, Pennsylvania, the company offers products such as Compliance Assured Enterprise, which delivers compliance packages for insurance carriers and their extended enterprises, and Compliance Assured Producer Network, designed to equip Compliance Officers with essential tools for managing risks related to extended enterprise compliance. By streamlining governance, risk, and compliance processes, Compliance Assurance aims to reduce compliance costs, mitigate risks, and enhance visibility within the insurance sector.

NanoPack

Venture Round in 2008
NanoPack, Inc. is a materials science company established in 2004 and located in Wayne, Pennsylvania. The company specializes in the development and marketing of barrier materials designed primarily for food packaging applications. Its product offerings include polyethylene terephthalate, polylactic acid, and oriented polypropylene barrier coated films, as well as liquid coatings that enhance packaging films. These innovative materials are utilized in a variety of consumer products, including snack foods, nuts, dried fruits, coffee, cereals, beef jerky, baked goods, confectionery items, spices, and air fresheners. NanoPack focuses on providing cost-effective and environmentally friendly solutions for the packaging industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.